Gen Digital Inc. engages in the provision of cyber safety solutions for consumers in the United States, Canada, Latin America, Europe, the Middle East, Africa, the Asia Pacific, and Japan. The company offers security and performance products under Norton, Avast, Avira, AVG, and CCleaner brands that provide real-time protection and maintenance for PCs, Macs, and mobile devices against malware, viruses, adware, and other online threats. It also provides identity protection solutions, including LifeLock Identity Theft Protection, Avast and AVG Secure Identity, Norton Identity Theft Protection, and Dark Web Monitoring for monitoring of credit reports, financial accounts, the dark web, and social media accounts to help safeguard customers' personal information. In addition, the company offers Virtual Private Network (VPN) solutions under Norton, Avast and AVG brands to enhance security and online privacy that allows customers to securely transmit and access private information, such as passwords, bank details, and credit card numbers, when using public Wi-Fi on PCs, Macs, and mobile iOS and Android devices; AntiTrack and Secure Browser products which helps to keep personal information and browsing activity anonymous while browsing online; and Privacy Monitor Assistant and BreachGuard products for removing customers' data from public data broker sites; and ReputationDefender, a white glove service that helps customers manage all aspects of their personal branding online, including search results, social media sites, and overall web presence. It markets and sells its products and related services through retailers, telecom service providers, hardware original equipment manufacturers, and employee benefit providers, as well as e-commerce platform. The company was formerly known as NortonLifeLock Inc. and changed its name to Gen Digital Inc. in November 2022. Gen Digital Inc. was founded in 1982 and is headquartered in Tempe, Arizona.

Gen Digital Inc.

The latest announcement is out from Qiagen ( ($QGEN) ). Qiagen has disclosed that the Dutch financial markets regulator AFM notified the company of...

BlackRock Raises Substantial Stake in Qiagen to Over 10%

Tecogen ( ($TGEN) ) has provided an announcement. On April 8, 2026, Tecogen Inc. extended the term of its Advisory Agreement with long-time adviser...

Tecogen Extends Advisory Agreement with John N. Hatsopoulos

An announcement from Legal & General ( ($GB:LGEN) ) is now available. Legal & General has confirmed the vesting of a second tranche of conditional ...

Legal & General confirms vesting of equity awards for asset management CEO Eric Adler

Legal & General ( ($GB:LGEN) ) has issued an update. Legal & General has disclosed the vesting of restricted share awards granted in April 2023 to ...

Legal & General executives receive vested share awards under bonus plan

Genflow Biosciences Plc ( ($GB:GENF) ) just unveiled an update. Genflow Biosciences reported that three-month follow-up data from its SLAB trial in...

Genflow sees sustained safety and efficacy in SIRT6 beagle trial

Legal & General ( ($GB:LGEN) ) has provided an announcement. Legal & General Group has repurchased 5,819,363 ordinary shares between 30 March and 2...

Legal & General Cancels 5.8 Million Shares in Latest Buyback Tranche

An announcement from NervGen Pharma ( ($NGEN) ) is now available. NervGen Pharma has secured alignment with the U.S. Food and Drug Administration o...

NervGen Wins FDA Alignment for Phase 3 RESTORE Trial in Chronic Tetraplegia

Genmin Ltd. ( ($AU:GEN) ) has provided an update. Genmin Ltd. has reported a change in the interests of director John Hodder, whose holdings are he...

Genmin Director John Hodder Sees 5 Million Options Expire

Genmin Ltd. ( ($AU:GEN) ) has shared an announcement. Genmin Limited disclosed a change in the interests of director Salvatore Pietro Amico, in lin...

Genmin director’s options lapse after reaching expiry date

Genmin Ltd. ( ($AU:GEN) ) has shared an announcement. Genmin Ltd has reported changes to its capital structure with the expiry of a large tranche o...

Genmin Options Lapse, Trimming Potential Future Dilution

Gencor ( ($GENC) ) has shared an update. At Gencor Industries’ annual meeting of stockholders held on April 3, 2026, shareholders elected John G. C...

Gencor Shareholders Reelect Directors and Ratify Auditor Decisions

There’s a lot to be optimistic about in the Healthcare sector as 2 analysts just weighed in on Milestone Scientific (MLSS) and NervGen Pharma (NGEN...

Analysts Offer Insights on Healthcare Companies: Milestone Scientific (MLSS) and NervGen Pharma (NGEN)

The latest announcement is out from Legal & General ( ($GB:LGEN) ). Legal & General has disclosed that several senior executives, including the Gro...

Legal & General Executives Buy Shares Under Employee Plan

Legal & General ( ($GB:LGEN) ) just unveiled an announcement. Legal & General has disclosed that its Group Chief Risk Officer and person dischargin...

Legal & General Discloses Share Sale by Chief Risk Officer

Legal & General ( ($GB:LGEN) ) has issued an update. Legal & General Group has admitted 126,987 new ordinary shares of £0.025 each to trading on th...

Legal & General Admits New Shares Under Employee SAYE Scheme

Legal & General ( ($GB:LGEN) ) has issued an update. Legal & General Group Plc has confirmed that as of 31 March 2026 its issued share capital comp...

Legal & General updates share capital and voting rights after share buyback

Legal & General ( ($GB:LGEN) ) has issued an update. Legal & General Group Plc has disclosed a transaction by its chair, Sir John Kingman, in line ...

Legal & General Chair Reports Purchase of Shares

Legal & General ( ($GB:LGEN) ) has shared an announcement. Legal & General has disclosed share purchases by three non-executive directors, Mark Jor...

Legal & General discloses board directors’ share purchases

An announcement from Legal & General ( ($GB:LGEN) ) is now available. Legal & General has confirmed the vesting of a portion of restricted share aw...

Legal & General Discloses Vesting of COO Katie Worgan’s Restricted Share Award

There’s a lot to be optimistic about in the Communication Services sector as 2 analysts just weighed in on Anterix (ATEX) and Genius Sports Limited...

Analysts Are Bullish on These Communication Services Stocks: Anterix (ATEX), Genius Sports Limited (GENI)

The latest update is out from Oragenics ( ($OGEN) ). On March 27, 2026, Oragenics’ board set June 29, 2026 as the date for the company’s 2025 annua...

Oragenics Sets New 2025 Annual Shareholder Meeting Date

Legal & General ( ($GB:LGEN) ) has issued an announcement. Legal & General Group has repurchased 8,087,004 of its ordinary shares between 23 and 27...

Legal & General cancels 8.1m shares in latest buyback tranche

An announcement from Hydrogenone Capital Growth Plc ( ($GB:HGEN) ) is now available. Hydrogen Capital Growth plc shareholders have approved resolut...

Hydrogen Capital Growth Wins Shareholder Backing to Delist and Go Private

Genel Energy ( ($GB:GENL) ) has provided an announcement. Genel Energy has granted new nil-cost share options to senior executives under its 2021 P...

Genel Energy boosts executive equity incentives with fresh nil-cost option awards

There’s a lot to be optimistic about in the Communication Services sector as 2 analysts just weighed in on Genius Sports Limited (GENI) and Alphabe...

Wall Street Analysts Are Bullish on Top Communication Services Picks

Jefferies analyst Hisae Kawamoto maintained a Buy rating on Pigeon Corporation on March 27 and set a price target of Yen1,950.00. The company’s sha...

Jefferies Remains a Buy on Pigeon Corporation (7956)

Gen Digital ( ($GEN) ) has shared an announcement. On March 27, 2026, Gen Digital Inc. amended its existing credit agreement by entering into a Thi...

Gen Digital Extends Credit Facility and Term Loan Maturities

The latest announcement is out from Legal & General ( ($GB:LGEN) ). Legal & General has disclosed an internal share transfer involving its Group Ch...

Legal & General CEO Transfers Shares to Spouse With No Change in Overall Stake

Agenus ( ($AGEN) ) has issued an update. On March 24, 2026, the U.S. District Court for the District of Massachusetts dismissed in its entirety a p...

Agenus Securities Class Action Dismissed, Legal Risks Ease

The latest announcement is out from Hydrogenone Capital Growth Plc ( ($GB:HGEN) ). Hydrogenone Capital Growth plc has announced a change in venue a...

Hydrogenone Capital Growth Updates Venue and Time for March General Meeting

There’s a lot to be optimistic about in the Healthcare sector as 2 analysts just weighed in on Repligen (RGEN) and Amylyx Pharmaceuticals Inc (AMLX...

Analysts Are Bullish on These Healthcare Stocks: Repligen (RGEN), Amylyx Pharmaceuticals Inc (AMLX)

Genmin Ltd. ( ($AU:GEN) ) just unveiled an announcement. Genmin Ltd has released a confidential investor presentation dated 9 February 2026 for the...

Genmin issues heavily qualified investor presentation for iron ore conference

Legal & General ( ($GB:LGEN) ) has shared an announcement. Legal & General Group has disclosed a share transaction by Group Chief Risk Officer Chri...

Legal & General discloses share sale by chief risk officer

In a report released today, from Citi maintained a Hold rating on Legal & General, with a price target of £2.49. In addition to Citi, Legal & Gener...

Citi Reaffirms Their Hold Rating on Legal & General (LGEN)

Legal & General ( ($GB:LGEN) ) has issued an update. Legal & General has repurchased 7.2 million of its ordinary shares between 16 and 20 March 202...

Legal & General Cancels 7.2 Million Shares in Latest Buyback Tranche

In a report released today, Mandeep Jagpal from RBC Capital maintained a Sell rating on Legal & General, with a price target of p220.00. Jagpal cov...

RBC Capital Keeps Their Sell Rating on Legal & General (LGEN)

Legal & General ( ($GB:LGEN) ) has issued an update. Legal & General has disclosed the vesting of part of a one-off recruitment share award granted...

Legal & General details vesting of CEO António Simões’ recruitment share award

The latest announcement is out from Genuit Group ( ($GB:GEN) ). Genuit Group reported that its chief executive officer, Joe Vorih, purchased 15,000...

Genuit Group CEO and CFO Boost Stakes With Share Purchases

UBS analyst Nasib Ahmed maintained a Hold rating on Legal & General today and set a price target of p250.00. According to TipRanks, Ahmed is a 5-st...

UBS Reaffirms Their Hold Rating on Legal & General (LGEN)

Craig-Hallum analyst Ryan Sigdahl maintained a Buy rating on Genius Sports Limited yesterday. The company’s shares closed today at $4.77. According...

Genius Sports Limited (GENI) Receives a Buy from Craig-Hallum

In a report released today, Chip Moore from Roth MKM maintained a Buy rating on Tecogen, with a price target of $10.00. Moore covers the Industrial...

Roth MKM Sticks to Their Buy Rating for Tecogen (TGEN)

Legal & General ( ($GB:LGEN) ) has shared an update. Legal & General has disclosed that Group Chief Risk Officer Chris Knight, a person discharging...

Legal & General discloses share sales by chief risk officer

Legal & General ( ($GB:LGEN) ) has issued an announcement. Legal & General has announced that Ric Lewis will retire from its Board after six years ...

Legal & General refreshes board with governance committee chair change

Legal & General ( ($GB:LGEN) ) has shared an announcement. Legal & General Group has repurchased 2,992,834 of its ordinary shares between 12 and 13...

Legal & General Cancels Nearly 3 Million Shares in Ongoing Buyback

Legal & General ( ($GB:LGEN) ) has issued an announcement. Legal & General has disclosed a share transaction by Group Chief Risk Officer Chris Knig...

Legal & General discloses share sale by Chief Risk Officer

Qiagen ( ($QGEN) ) has shared an announcement. Qiagen has disclosed a notification from the Dutch financial regulator AFM showing that BlackRock, I...

BlackRock Discloses 10.29% Capital Interest and 11.43% Voting Stake in Qiagen

Qiagen ( ($QGEN) ) has shared an update. Qiagen has disclosed a voting rights announcement after the Dutch financial regulator AFM notified the com...

BlackRock Reports 10.6% Capital and 11.8% Voting Stake in Qiagen

Craig-Hallum analyst Ryan Sigdahl reiterated a Buy rating on Genius Sports Limited yesterday. The company’s shares closed today at $5.17. Sigdahl c...

Craig-Hallum Sticks to Its Buy Rating for Genius Sports Limited (GENI)

In a report released today, Greg Gibas from Northland Securities maintained a Buy rating on Genius Sports Limited, with a price target of $12.00. A...

Genius Sports Limited (GENI) Gets a Buy from Northland Securities

Kepler Capital analyst Fahad Changazi maintained a Sell rating on Legal & General on March 11 and set a price target of p241.61. The company’s shar...

Kepler Capital  Remains a Sell on Legal & General (LGEN)

The latest announcement is out from Oragenics ( ($OGEN) ). Oragenics has secured final ethics approval in Australia to begin a Phase IIa clinical t...

Oragenics Advances Concussion Drug Trial and Explores CNS Asset Acquisitions

The latest announcement is out from Qiagen ( ($QGEN) ). Qiagen disclosed that the Dutch markets regulator AFM has published a voting rights notific...

BlackRock Builds Significant Stake in Qiagen with Over 11% of Voting Rights

Qiagen ( ($QGEN) ) has provided an update. Qiagen disclosed that the Netherlands Authority for the Financial Markets has notified the company of a ...

Qiagen discloses Bank of America’s 3.05% stake following AFM notification

Berenberg Bank analyst Robert Chantry reiterated a Buy rating on Genuit Group today and set a price target of p500.00. Chantry covers the Industria...

Berenberg Bank Sticks to Their Buy Rating for Genuit Group (GEN)

In a report released today, Priyal Woolf from Jefferies reiterated a Buy rating on Genuit Group, with a price target of p394.00. According to TipRa...

Genuit Group (GEN) Receives a Buy from Jefferies

The latest update is out from Genuit Group ( ($GB:GEN) ). Genuit Group will host a live online investor presentation on 17 March 2026 to discuss it...

	A	B	C	D
1	Symbol	Price	Change	Volume
2	GEN	$18.37	-2.75%	8.60M
3
4
5

	A	B	C	D
1	Symbol	Price	Change	Vol
2	GEN	$18.37	-2.8%	8.60M
3
4
5
6

GEN

GEN

Get Gen Digital Inc. Data in Excel

Get Gen Digital Inc. Data in Excel